|Year : 2010 | Volume
| Issue : 4 | Page : 137-142
Scope and limitations of minimal invasive surgery in practice of pediatric surgical oncology
Sushmita Bhatnagar1, Yogesh Kumar Sarin2
1 Department of Pediatric Surgery, B. J. Wadia Hospital for Children, Acharya Donde Marg, Parel, Mumbai - 400 018, India
2 Maulana Azad Medical College and L. N. Hospital, New Delhi - 110 001, India
|Date of Web Publication||28-Jan-2011|
56/B, Venus Apartments, Worli Sea Face, Worli, Mumbai - 400 018
Source of Support: None, Conflict of Interest: None
Management of Solid tumors in children needs a comprehensive multimodality protocol based treatment plan. Open surgical removal of the tumors occurring in any of the sites such as abdomen, thorax, chest wall, HFN (head, face, neck), brain and extremities, is the option which has been traditionally practiced even in the present era and in most of the centers. Nevertheless with the advances in science and technology and with ever increasing usage and expertise of laparoscopy in children, it's application has extended to treatment of solid tumors in children. A review of the scope of such intervention as well as the limitations of minimal invasive surgery in this specialized field of pediatric surgery has been attempted in this article.
Keywords: Indications and limitations, minimally invasive surgery, solid tumors
|How to cite this article:|
Bhatnagar S, Sarin YK. Scope and limitations of minimal invasive surgery in practice of pediatric surgical oncology. Indian J Med Paediatr Oncol 2010;31:137-42
|How to cite this URL:|
Bhatnagar S, Sarin YK. Scope and limitations of minimal invasive surgery in practice of pediatric surgical oncology. Indian J Med Paediatr Oncol [serial online] 2010 [cited 2019 Oct 17];31:137-42. Available from: http://www.ijmpo.org/text.asp?2010/31/4/137/76198
| Introduction|| |
In 1911, the Swiss surgeon HC Jacobaeus reported the use of diagnostic laparoscopy in a large number of patients with a variety of conditions including cancer.  However, little progress was made in developing the role of minimal invasive surgery (MIS) in malignant disease for over 70 years. The technologic advances in the late 1980s with the introduction of miniaturized video cameras resulted in a dramatic escalation in the use of MIS. Its use in patients with malignancies has been slower to evolve; however, it is gaining greater acceptance for use in adult cancer patients. MIS is now commonly used for many applications in adult surgical oncology, including biopsy and resection of malignant disease in the chest and abdominal cavities, mediastinal and retroperitoneal lymph node dissection, staging of abdominal, pelvic and thoracic malignancies, and management of therapeutic complications.
As the general use of MIS in pediatric patients has lagged behind its use for adult patients, so has been its use in infants and children with malignancies. It has not, as yet, been widely accepted for more than diagnostic purposes and there are only a few reports describing the use of ablative MIS in infants and children with solid tumors. There are skeptics even today who feel that laparoscopy is not a complete form of laparotomy and that it might result in an inadequate or inappropriate management due to misdiagnosis.  The main concerns that have contributed to the limited use of minimal access surgery in these patients include the following.
Loss of tactile sensation: This is important when trying to evaluate the thoracic or peritoneal cavities for tumor spread and lymph node involvement when, for example, attempting therapeutic resection of pulmonary metastases in patients with osteosarcoma, or accurately staging a patient with an abdominal neuroblastoma.
Tumor spill: Spill of a Wilms' tumor, for example, has a significant impact on tumor staging, therapeutic approach and, ultimately, prognosis. In addition, a number of pediatric tumors, such as pleuro-pulmonary blastoma or malignant thymoma, are not responsive to treatment modalities other than surgical resection. Tumor spill often leads to local recurrence that can be ultimately very difficult to treat.
Tumor recurrence at trocar sites: Although there are few reports of this phenomenon in adult patients, pediatric surgical oncologists continue to be concerned about this issue,  in spite of none of the reports encountering port site recurrence (PSR). 
Removal of tumor specimens from the abdominal or thoracic cavities: In order to retain the benefits of the minimal access approach, specimens are often morcellated so that they can be removed through the smaller incisions. Although it has been shown that the use of a tissue morcellator does not interfere with adequate histologic evaluation of the tissue,  concerns remain, especially with regard to the ability to assess the margins of resection and gross anatomic relationships.  Tumor size, margins and renal vein involvement cannot be assessed once Wilms' tumor is morcellated. ,
Nevertheless, as technology continues to advance and the skill and comfort of pediatric surgeons with minimally invasive approaches increase, its use for children with cancer is also likely to increase. The general benefits of a minimally invasive approach, such as cosmetic appearance, reduced hospital stay, faster recovery, no/minimal bowel adhesions, much less pain and discomfort, reduced analgesic requirement, minimal postoperative disability, shorter length of postoperative ileus and rapid wound healing are worth noting in these children with tumors who generally need long-term treatment. , A good example is the role of MIS in management of children with osteogenic sarcomas, who may undergo multiple procedures for resectable lung metastases.
| Indications and Advantages of Minimal Invasive Surgery|| |
Since 1971, when Klimkovich et al.  reported the use of thoracoscopy in children for diagnosis of mediastinal masses and cysts and masses of pulmonary parenchyma, there have been many reports from across the world, which have cemented the presence of MIS in surgical management of solid tumors in children. ,,,,,,,,, The most recent expansion of MIS has been robotic surgery which provides an additional advantage in treating children with solid tumors of any age as described in a retrospective review of 100 consecutive cases. 
The various current indications and advantages of MIS in pediatric extra-cranial solid tumors are detailed below.
Most of the extracranial, solid tumors of infancy and childhood are treated with a multimodal approach. The treatment paradigm for large tumors usually begins with an initial biopsy with subsequent delayed primary resection. Therefore, biopsy of a new mass in a child either by a laparoscopic or thoracoscopic approach is a common indication. These can often also be approached by a radiographically guided percutaneous biopsy, although direct visualization of the lesion often gives additional anatomic detail and may provide visual confirmation of adequate hemostasis. In addition, with the current increasing emphasis on the procurement of tumor tissue for biologic studies, the laparoscopic or thoracoscopic approach may be increasingly favored for its ability to obtain more tissue while remaining minimally invasive. The diagnostic accuracy for minimal access procedures has typically been high, generally being reported in the range of 85-100%. The avoidance of large incisions that often led to postoperative ileus and atelectasis, in conjunction with this high diagnostic accuracy permitting the prompt initiation of appropriate chemotherapy, is a significant advantage. In addition, diminished intraperitoneal and intrathoracic adhesions after a minimally invasive biopsy may be advantageous when performing second look or delayed primary surgery. An exception to this approach of biopsy of large tumors is Wilms' tumor, in which transabdominal biopsy causes inevitable tumor spill into the peritoneal cavity thus upstaging the disease.
Tumors in the early stages can be excised by MIS, for example, neuroblastoma, Wilms' tumor, etc. Several articles report laparoscopic excision of neuroblastoma, which claim superiority over conventional surgical procedures in early recovery and ability to begin chemotherapy soon after surgery. Though there are specific pre-requisites for laparoscopic excision of neuroblastoma, there is a clear and definite role of MIS in excising these tumors in children. ,,,,,,, Nephrectomy for Wilms' tumor is another common surgery performed in children. With preoperative chemotherapy, nephrectomy is possible using MIS and intraperitoneal morcellation of tumor may not be needed.  Several other tumors completely excised by laparoscopy reported in literature include adrenal tumors, ,,, Altman tpe II-IV sacrococcygeal teratomas,  presacral ganglioneurofibroma  and ovarian teratomas (oophorectomy). ,, The resection of pheochromocytoma and even those arising from an extra-adrenal site laparoscopically  proves that pediatric surgical oncology MIS has advanced and is finding more and more indications of its use. Another breakthrough in MIS in pediatric oncology has been resection of liver tumors in children. ,, Very few reports are available, but the possibility of such a major surgery being done laparoscopically is exciting, provided the selection criteria for its use are met to ensure a successful outcome. MIS resection of osteoid osteoma of long bones is another landmark in the field of MIS in pediatric oncology, without bone grafting or internal fixation, excellent cosmetic appearance, early mobilization and no perioperative complications. 
Although there have been significant improvements in the radiographic assessment of the extent of malignancy, discrepancies between radiographic and surgical staging can occur. With the development and acceptance of MIS may come a greater emphasis on the need for surgical/pathologic staging. Accurate staging will become even more important as pediatric protocols attempt to decrease the intensity of treatment, while maintaining high rates of cure currently achieved for many pediatric malignancies. Lymph nodes in the chest and abdomen can be easily sampled through a minimally invasive approach to stage thoracic and abdominal tumors such as neuroblastoma, germ cell tumors, etc. Occasionally, intra-abdominal lymph nodes may need to be evaluated for extra-abdominal primaries also. For example, iliac lymph nodes need to be evaluated in patients with testicular tumors when an abnormality is detected on computed tomography (CT) scan. This is important for staging in rhabdomyosarcoma and can, additionally, be therapeutic for patients with a germ cell tumor of the testis.
During staging, the liver surface can be inspected for small, metastatic deposits and biopsy performed under direct vision, with the confirmation that hemostasis has been achieved. The peritoneal and pleural surfaces, sites of tumor spread not always accurately assessed by imaging studies, can be completely evaluated for disease. Finally, nodules of the pulmonary parenchyma, detected by CT as part of a staging evaluation, can be biopsied to confirm or exclude the presence of metastatic disease. This determination can have a significant impact on the treatment plan and ultimate prognosis for children with cancer.
Radiographic imaging has shown an error in staging when compared to surgical staging of approximately 30% for children with Hodgkin's disease. However, because treatment of these patients has been so successful, with a high cure rate and low morbidity, surgical staging is no longer a part of the routine staging of these children. However, there is still interest in an MIS approach to the evaluation of nodal regions with equivocal CT in cases where disease stage and, consequently, treatment will be significantly impacted. This is particularly true when distinguishing stage II from stage III Hodgkin's disease where the use of alkylating agents and radiation therapy is being considered. Whether routine, complete surgical staging will return to favor as the minimal morbidity and diagnostic accuracy of laparoscopy in evaluating the liver, spleen and lymph nodes is recognized, is uncertain.
Determination of resectability
The determination of resectability of a primary tumor is a very useful indication for laparoscopy or thoracoscopy. MIS has been often used for the evaluation of liver tumors, tumors of the chest wall and large pelvic tumors, especially ovarian tumors. The minimally invasive approach can be used to evaluate anatomic relationships, invasion of vital structures and to assess whether multifocal disease is present. If a tumor is determined to be unresectable, a biopsy can be easily performed at the same time if this has not already been done.
Monitoring response to neo-adjuvant chemotherapy
During the multimodality treatment of solid tumors, one needs to monitor the response of solid tumor to neo-adjuvant chemotherapy. Imaging techniques frequently could provide only limited information. Laparoscopy can be thence used to visualize the tumor and help in formulating further management plan, for example, neuroblastomas, germ cell tumor, etc. Also, laparoscopy could be useful for excising the residual mass in the same sitting. Liver biopsy could be safely done during assessment via laparoscope when indicated.
Second-look, recurrence, metastatic disease
Second-look operations can be performed even after a primary open resection. Tumor recurrence, both locoregional and metastatic, can be documented through a minimal access approach. This has been done most often for pulmonary metastases and retroperitoneal sites. Because pulmonary metastases are usually peripheral lesions, they can be approached easily by thoracoscopy. In certain histologic types, resection of metastatic lesions may be both diagnostic and therapeutic, favorably influencing long-term survival. One drawback, however, to the thoracoscopic approach is the inability to palpate the lung to exclude the presence of smaller metastatic foci. It is unclear at this time, however, whether failing to identify and resect these lesions early will impact on patient survival.
Infectious and other treatment associated complications
Pediatric cancer patients frequently undergo intensive, multimodal therapy and a number of complications that require surgical intervention can arise during the course of their treatment. Many of these can be dealt with using a minimally invasive approach. Patients will often become anorexic as a result of their treatment and may benefit from a laparoscopic gastrostomy tube placement. Children who are unable to tolerate enteral feeds of any type and require total parenteral nutrition (TPN) occasionally develop cholelithiasis as a consequence. Laparoscopic cholecystectomy can be performed in these patients for symptomatic stones or for acute cholecystitis. Patients with brain tumors may develop symptomatic gastroesophageal reflux. If the reflux is refractory to medical management, they may benefit from a laparoscopic Nissen fundoplication. Laparoscopic oophoropexy is often performed for females who are to undergo abdominopelvic irradiation.
The children with malignancies are immunosuppressed both because of their malignancy as well as their treatment. MIS can be a very useful technique for evaluating lesions seen on radiographic work-up. Diagnostic tissue can be obtained to distinguish among tumor, a benign process and an infectious process and tissue for culture obtained to identify particular inciting organisms. This situation arises most frequently with lesions (or diffuse processes) of the lung, in which a thoracoscopic lung biopsy can be performed, but may occur in the liver or retroperitoneum.
Ligation of tumor vessels
Laparoscopic ligation of vessels before surgical intervention is of definite benefit in terms of ease of surgery and bloodless field intraoperatively. Sacrococcygeal teratoma is the only tumor wherein laparoscopic ligation of median sacral artery has been successfully performed by several authors. ,,
| Contraindications of Minimal Invasive Surgery|| |
Absolute contraindications to MIS in pediatric surgical oncology include:
- associated coagulation disorder,
- respiratory compromise of any etiology, and
- an infective focus, especially in the anterior abdominal wall, especially in the periumbilical region.
Relative contraindications include:
- extensive previous surgery that has resulted in dense intra-abdominal/ thoracic adhesions and
- ablative MIS when tumor is very huge as it may lead to tumor spillage with its sequelae.
| Complications of Minimal Invasive Surgery|| |
The conversion rate mentioned for pediatric surgical MIS procedures is usually quoted between 7 and 10%,  but they are understandably higher in diagnostic and ablative procedures of tumors (29%).  Judicious conversion to open surgery is not to be considered as a complication in any case. However, several complications of MIS have been cited in the literature.
It is the most dreaded complication of any MIS procedure; this may hamper postoperative recovery. 
Trocar site herniation
Trocar site herniation is another known complication of MIS in children  and is seen to occur more often in children less than 5 years of age. 
The complication specific to cancer surgery in MIS is that of PSR. PSR is defined as local, circumscribed tumor growth at the site of one or more trocar sites or at the incision site after laparoscopic or thoracoscopic surgery for cancer. PSR is localized within the abdominal or thoracic walls, within the scar tissue and involves initially the dermis and the subcutaneous fat and usually not the muscular layer. If these lesions occur within a few months (approximately up to 200 days) after endoscopic surgery, they fit into the criteria of PSR. PSR is not identical with peritoneal metastases, serosal invasion, skin metastases. A comprehensive literature search revealed only one case of PSR reported in pediatric age group after thoracoscopic resection of pulmonary metastases owing to osteogenic sarcoma.  On the contrary, a study conducted by the Japanese Society of Pediatric Endosurgeons did not reveal any PSR amongst 29 institutes which performed MIS procedures in children with tumors, and thus concluded that it is a rare phenomenon in children. 
Tumor spillage after morcellation
This is the most dreaded problem during extraction of the tumor. A study on cytologic washings retrieved from the bag used for specimen collection and morcellation revealed that malignant cells can be identified from the washing of the bag which had contained morcellated tissue, thus implying that whenever there is tumor spillage during morcellation, malignant cells do get lodged into surrounding tissue and alter the stage of the tumor.  Pathologic examination of the morcellated tissue is definitely more challenging, tedious and time consuming. As of today, majority would recommend separate incision wherein the tumor is extracted in toto without spillage.
| Other Unknown Fears|| |
MIS is still evolving. A lot of questions still remain unanswered:
- whether tumor recurrence rates are higher with MIS,
- whether trocar site recurrence and seedling occurs with MIS,
- whether incomplete resections with MIS have different implications as compared to open surgery and
- Is there dissemination of tumor cells after carbon dioxide insufflation?
| Conclusions|| |
The role of MIS in all children with tumors is still debatable. MIS is not simply utilization of new technology, but rather a philosophy that aims to minimize the physiologic consequences of an operation, which include pain, scarring, stress response and disability. In comparison to open surgery, MIS has several advantages: less pain, faster recovery time and improved cosmesis (much smaller incisions). However, any surgical technique to be established as better than the standard requires a long-term dedicated study about its applicability as well as complications and safety of use. Clearly, carefully controlled randomized studies are needed to help determine the benefits and drawbacks of this new, evolving methodology.
In the recent times, with improved instrumentation and skills in pediatric MIS, the treatment and staging of tumors in children laparoscopically is becoming more and more popular. There are still several limitations to the use of laparoscopy in pediatric oncology and it is doubtful that MIS will replace open surgery but future technical developments and its applications are difficult to predict.
| References|| |
|1.||Hatzinger M, Kwon ST, Langbein S, Kamp S, Häcker A, Alken P. Hans Christian Jacobaeus: Inventor of human laparoscopy and thoracoscopy. J Endourol 2006;20:848-50. |
|2.||Hsu TC. Intra-abdominal lesions could be missed by inadequate laparoscopy. Am Surg 2008;74:824-6. |
|3.||Sartorelli KH, Partrick D, Meagher DP Jr. Port-site recurrence after thoracoscopic resection of pulmonary metastasis owing to Osteogenic sarcoma. J Pediatr Surg 1996;31:1443-4. |
|4.||Duarte RJ, Dénes FT, Cristofani LM, Srougi M. Laparoscopic nephrectomy for Wilms' tumor. 2009;9:753-61. |
|5.||Landman J a , Lento P a , Hassen W a , Unger a P, Waterhouse R. Feasibility of pathological evaluation of morcellated kidneys after radical nephrectomy. J Urol 2000;164:2086-9. |
|6.||Lobe TE, Schropp KP, Joyner R, Losater O, Jenkins J. The suitability of automatic tissue morcellation for the endoscopic removal of large specimens in pediatric surgery. J Pediatr Surg1994;29:232-4. |
|7.||Chan KW, Lee KH, Tam YH, Yeung CK. Minimal Invasive Surgery in Pediatric Solid Tumors. J Laparoendosc Adv Surg Tech A 2007;17:817-20th |
|8.|| Kaouk JH, Gill IS. Laparoscopic Radical Nephrectomy: Morcellate or Leave Intact? Leave Intact. Rev Urol 2002;4:38-42. |
|9.||Tagge EP. Minimal access cancer management in children. In: Greene FL, Heniford BT, editors. Springer, USA: Minimally Invasive Cancer Management; 2001. p. 335-46. |
|10.||Ehrlich PF, Newman KD, Haase GM, Lobe TE, Wiener ES, Holcomb GW. Lessons learned from a failed multi-institutional randomized controlled study. J Pediatr Surg 2002;37:431-6. |
|11.||Klimkovich IG, Gel'dt VG, Okulov AB, Ovchinnikov AA, Poliakova ON. Thorascopy in children. Khirurgiia (Mosk) 1971;47:19-24. |
|12.||Ryckman FC, Rodgers BM. Thoracoscopy for intrathoracic neoplasia in children. J Pediatr Surg 1982;17:521-4. |
|13.||Karamehmedovic O, Dangel P, Hirsig J, Rickham PP. Laparoscopy in childhood. J Pediatr Surg 1977;12:75-81. |
|14.||Rogers DA, Lobe TE, Schropp KP. Evolving uses of laparoscopy in children. Surg Clin North Am 1992;72:1299-313. |
|15.||Holcomb GW 3 rd , Tomita SS, Haase GM, Dillon PW, Newman KD, Applebaum H, et al. Minimally invasive surgery in children with cancer. Cancer 1995;76:121-8. |
|16.||Holcomb GW. Indications for Minimally Invasive Surgery in Pediatric Oncology. Pediatr Endosurg Innovative Tech 2001;5:299-303. |
|17.||Sailhamer E, Jackson CC, Vogel AM, Kang S, Wu Y, Chwals WJ, et al. Minimally invasive surgery for pediatric solid neoplasms. Am Surg 2003;69:566-8. |
|18.||Spurbeck WW, Davidoff AM, Lobe TE, Rao BN, Schropp KP, Shochat SJ. Minimally invasive surgery in pediatric cancer patients. Ann Surg Oncol 2004;11:340-3. |
|19.||Metzelder ML, Kuebler JF, Shimotakahara A, Glueer S, Grigull L, Ure BM. Role of diagnostic and ablative minimally invasive surgery for pediatric malignancies. Cancer 2007;109:2343-8. |
|20.||Leclair MD, Sarnacki S, Varlet F, Heloury Y. Minimally-invasive surgery in cancer children. Bull Cancer 2007;94:1087-90. |
|21.||Chan KW, Lee KH, Tam YH, Yeung CK. Minimal Invasive Surgery in Pediatric Solid Tumors. J Laparoendosc Adv Surg Tech A 2007;17:817-20 |
|22.||Meehan JJ, Sandler A. Pediatric robotic surgery: A single-institutional review of the first 100 consecutive cases. Surg Endosc 2008;22:177-82. |
|23.||Leclair MD, de Lagausie P, Becmeur F, Varlet F, Thomas C, Valla JS, et al. Laparoscopic resection of abdominal neuroblastoma. Ann Surg Oncol 2008;15:117-24. |
|24.||DeBerrebi D, Michon J, Philippe-Chomette P, El Ghoneimi A, Garel C, Brisse H, et al. Laparoscopic adrenal surgery for neuroblastomas in children. J Urol 2003;170:932-5. |
|25.||Iwanaka T, Kawashima H, Uchida H. The laparoscopic approach of neuroblastoma. Semin Pediatr Surg 2007;16:259-65. |
|26.||Al-Shanafey S, Habib Z. Feasibility and safety of laparoscopic adrenalectomy in children: Special emphasis on neoplastic lesions. J Laparoendosc Adv Surg Tech A 2008;18:306-9. |
|27.||Saad DF, Gow KW, Milas Z, Wulkan ML. Laparoscopic adrenalectomy for neuroblastoma in children: A report of 6 cases. J Pediatr Surg 2005;40:1948-50. |
|28.||Iwanaka T, Arai M, Ito M, Kawashima H, Matoba K, Imaizumi S. Challenges of laparoscopic resection of abdominal neuroblastoma with lymphadenectomy. A preliminary report. Surg Endosc 2001;15:489-92. |
|29.||Rescorla FJ. Malignant adrenal tumors. Semin Pediatr Surg 2006;15:48-56. |
|30.||Misseri R. Adrenal surgery in the pediatric population. Curr Urol Rep 2007;8:89-94. |
|31.||Varlet F, Stephan JL, Guye E, Allary R, Berger C, Lopez M. Laparoscopic radical nephrectomy for unilateral renal cancer in children. Surg Laparosc Endosc Percutan Tech 2009;19:148-52. |
|32.||Rescorla FJ. Malignant adrenal tumors. Semin Pediatr Surg 2006;15:48-56. |
|33.||Misseri R. Adrenal surgery in the pediatric population. Curr Urol Rep 2007;8:89-94. |
|34.||Bissada MA, Safwat AS, Seyam RM, Al Sobhi S, Hanash KA, Bissada NK. Familial pheochromocytoma. Urol Oncol 2008;26:361-3. |
|35.||Kravarusic D, Pinto-Rojas A, Al-Assiri A, Sigalet D. Laparoscopic resection of extra-adrenal pheochromocytoma--case report and review of the literature in pediatric patients. J Pediatr Surg 2007;42:1780-4. |
|36.||Bax NM, van der Zee DC. The laparoscopic approach to sacrococcygeal teratomas. Surg Endosc 2004;18:128-30. |
|37.||Köhler C, Kühne-Heid R, Klemm P, Tozzi R, Schneider A. Resection of presacral ganglioneurofibroma by laparoscopy. Surg Endosc 2003;17:1499 |
|38.||Davidoff AM, Hebra A, Kerr J, Stafford PW. Laparoscopic oophorectomy in children. J Laparoendosc Surg 1996;1:S115-9. |
|39.||Jawad AJ, Al-Meshari A. Laparoscopy for ovarian pathology in infancy and childhood. Pediatr Surg Int 1998;14:62-5. |
|40.||Barbancho DC, Novillo IC, Vázquez AG, Díaz ML, Sánchez RT, Gordo MB. Laparoscopy for ovarian tumors in children. Cir Pediatr 2007;20:15-8. |
|41.||Yeung CK, Chowdhary SK, Chan KW, Lee KH, Till H. Atypical laparoscopic resection of a liver tumor in a 4-year-old girl. J Laparoendosc Adv Surg Tech A 2006;16:325-7. |
|42.||Yoon YS, Han HS, Choi YS, Lee SI, Jang JY, Suh KS, et al. Total laparoscopic left lateral sectionectomy performed in a child with benign liver mass. J Pediatr Surg 2006;41:e25-8. |
|43.||Dutta S, Nehra D, Woo R, Cohen I. Laparoscopic resection of a benign liver tumor in a child. J Pediatr Surg 2007;42:1141-5. |
|44.||Ofluoglu O, Erol B, Mik G, Coskun C, Yildiz M. Image-guided minimal invasive surgical resection of osteoid osteomas of the long bones. Acta Orthop Traumatol Turc 2006;40:207-13. |
|45.||Lukish JR, Powell DM. Laparoscopic ligation of the median sacral artery before resection of a sacrococcygeal teratoma. J Pediatr Surg 2004;39:1288-90. |
|46.||Bax NM, van der Zee DC. Laparoscopic ligation of the median sacral artery before excision of type I sacrococcygeal teratomas. J Pediatr Surg 2005;40:885. |
|47.||Bax NM, van der Zee DC. Laparoscopic clipping of the median sacral artery in huge sacrococcygeal teratomas. Surg Endosc 1998;12:882-3. |
|48.||Meng M, Miller T, Cha I, Stoller MA. Cytology of morcellated Renal Specimens: Significance in Diagnosis and Dissemination. J Urol 2003;169:45-8. |
|49.||Te Velde EA, Bax NM, Tytgat SH, De Jong JR, Travassos DV, Kramer WL, et al. Minimally invasive pediatric surgery: Increasing implementation in daily practice and resident's training. Surg Endosc 2008;22:163-6. |
|50.||Waldhaussen JH. Incisional hernia in a 5-mm trocar site following pediatric laparoscopy. J Laparoendosc Surg 1996;6:S89-90. |
|51.||Paya K, Wurm J, Fakhari M, Felder-Puig R, Puig S. Trocar-site hernia as a typical postoperative complication of minimally invasive surgery among preschool children. Surg Endosc 2008;22:2724-7. |
|52.||Iwanaka T, Arai M, Yamamoto H, Fukuzawa M, Kubota A, Kouchi K, et al. No incidence of port-site recurrence after endosurgical procedure for pediatric malignancies. Pediatr Surg Int 2003;19:200-3. |